Add to ORKGCopyright © 2015 Alessandro Varrica et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. S100B protein, previously proposed as a consolidated marker of brain damage in congenital heart disease (CHD) newborns who underwent cardiac surgery and cardiopulmonary bypass (CPB), has been progressively abandoned due to S100B CNS extra-source such as adipose tissue.Thepresent study investigatedCHDnewborns, if adipose tissue contributes significantly to S100B serum levels.Methods.We conducted a prospective study in 26CHD infants, without preexisting neurological disorders, ...
BACKGROUND: The release of neuron-specific astroglial S-100 protein to the cerebrospinal fluid is a ...
Cardiopulmonary bypass (CPB) is used in most operations when correcting congenital heart malformatio...
AbstractBackground: The release of neuron-specific astroglial S-100 protein to the cerebrospinal flu...
Background. S100B protein, previously proposed as a consolidated marker of brain damage in congenita...
Aims: S100B has been proposed as a consolidated marker of brain damage in infants with congenital he...
S100B protein has been recently proposed as a consolidated marker of brain damage and death in adult...
- S100B protein has been recently proposed as a consolidated marker of brain damage and death in adu...
S100B protein has been recently proposed as a consolidated marker of brain damage and death in adult...
Neurodevelopmental problems in patients with congenital heart diseases (CHD) have become focus of an...
Copyright © 2013 A. Thaler et al.This is an open access article distributed under the Creative Commo...
The brain-derived protein S100B is a 21 Kda dimerand have been used as a serum marker for brain dama...
BACKGROUND: Brain hyperthermia, accompanying the rewarming phase of cardiopulmonary bypass (CPB), ha...
Copyright © 2013 Yukun Cao et al. This is an open access article distributed under the Creative Comm...
BACKGROUND: The release of neuron-specific astroglial S-100 protein to the cerebrospinal fluid is a ...
Cardiopulmonary bypass (CPB) is used in most operations when correcting congenital heart malformatio...
AbstractBackground: The release of neuron-specific astroglial S-100 protein to the cerebrospinal flu...
Background. S100B protein, previously proposed as a consolidated marker of brain damage in congenita...
Aims: S100B has been proposed as a consolidated marker of brain damage in infants with congenital he...
S100B protein has been recently proposed as a consolidated marker of brain damage and death in adult...
- S100B protein has been recently proposed as a consolidated marker of brain damage and death in adu...
S100B protein has been recently proposed as a consolidated marker of brain damage and death in adult...
Neurodevelopmental problems in patients with congenital heart diseases (CHD) have become focus of an...
Copyright © 2013 A. Thaler et al.This is an open access article distributed under the Creative Commo...
The brain-derived protein S100B is a 21 Kda dimerand have been used as a serum marker for brain dama...
BACKGROUND: Brain hyperthermia, accompanying the rewarming phase of cardiopulmonary bypass (CPB), ha...
Copyright © 2013 Yukun Cao et al. This is an open access article distributed under the Creative Comm...
BACKGROUND: The release of neuron-specific astroglial S-100 protein to the cerebrospinal fluid is a ...
Cardiopulmonary bypass (CPB) is used in most operations when correcting congenital heart malformatio...
AbstractBackground: The release of neuron-specific astroglial S-100 protein to the cerebrospinal flu...